US Patent Issued to GEN1E LIFESCIENCES on June 17 for "Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors" (California Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,024, issued on June 17, was assigned to GEN1E LIFESCIENCES INC. (Palo Alto, Calif.).

"Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors" was invented by Adam Galan (Alameda, Calif.), Wendy Luo (Palo Alto, Calif.) and Ritu Lal (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Substituted naphthyl p38Alpha mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and the use of the substituted naphthyl p38Alpha mitogen-activated protein kinase inhibitors and pharmaceutical compositions thereof for treating diseases are disclosed."

The patent was filed on March 27, 2024, under Application...